Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EV71 vaccine co-administration with hepatitis B and meningococcal vaccines
CTR20171044Phase 4Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Apr 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of enterovirus 71 vaccine (vero cell), inactivated in hepatitis B (HBV), meningococcal disease, sponsored by Sinovac Biotech Ltd.. Started Apr 2018; status: completed.
02
Drugs
enterovirus 71 vaccine (vero cell), inactivated
03
Conditions
hepatitis B (HBV)meningococcal disease
Beyond the preview
Go deeper on CTR20171044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171044.